FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Vibration NOS Vibration - treatment
Vibration NOS Vibration - treatment
Vibration of cervix Uterine cervix manipulation
Vibration of cervix Uterine cervix manipulation
Vibrio anguillarium Listonella anguillarum (organism)
Vibrio carchariae Vibrio harveyi
Vibrio costicola Salinivibrio costicola
Vibrio damsela Photobacterium damselae (organism)
Vibrio fischeri Aliivibrio fischeri
Vibrio hollisae Grimontia hollisae (organism)
Vibrio marinus Moritella marina (organism)
Vibrio trachuri Vibrio harveyi
Vibrionaceae ichthyoenteri Vibrio ichthyoenteri (organism)
Victimizing others Abusive behavior towards people (finding)
Villonodular synovitis Diffuse tenosynovial giant cell tumor
Villonodular synovitis NOS Diffuse tenosynovial giant cell tumor
Villonodular synovitis of multiple sites Diffuse tenosynovial giant cell tumor
Villonodular synovitis of other specified site Diffuse tenosynovial giant cell tumor
Villonodular synovitis of unspecified site Diffuse tenosynovial giant cell tumor
Villous adenoma Villous adenoma (morphologic abnormality)
Vinblastine sulfate 30mg/30mL conventional release solution for injection Product containing only vinblastine in parenteral dose form (medicinal product form)
Vinblastine sulfate 30mg/30mL infusion Product containing only vinblastine in parenteral dose form (medicinal product form)
Vinblastine sulfate 50mg/50mL conventional release solution for infusion Product containing only vinblastine in parenteral dose form (medicinal product form)
Vinblastine sulfate 50mg/50mL infusion Product containing only vinblastine in parenteral dose form (medicinal product form)
Vinca alkaloid Vinca alkaloid
Vincristine 1mg powder and solvent for injection solution vial Vincristine only product in parenteral dose form
Vincristine 1mg powder for injection solution vial Vincristine only product in parenteral dose form
Vincristine 2mg powder and solvent for injection solution vial Vincristine only product in parenteral dose form
Vincristine 2mg powder for injection solution vial Vincristine only product in parenteral dose form
Vincristine 5mg powder and solvent for injection solution vial Vincristine only product in parenteral dose form
Vincristine 5mg powder for injection solution vial Vincristine only product in parenteral dose form
Vincristine sulfate 10mg/50mL conventional release solution for infusion Vincristine only product in parenteral dose form
Vincristine sulfate 10mg/50mL infusion Vincristine only product in parenteral dose form
Vincristine sulfate 5mg/50mL conventional release solution for infusion Vincristine only product in parenteral dose form
Vincristine sulfate 5mg/50mL infusion Vincristine only product in parenteral dose form
Vinorelbine 10mg/1mL intravenous solution Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Vinorelbine 50mg/5mL intravenous solution Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Vinorelbine tartrate 10mg/mL injection solution 1mL vial Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Vinorelbine tartrate 10mg/mL injection solution 5mL vial Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Vinorelbine tartrate 10mg/mL solution Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Viper type C oncovirus Viper retrovirus (organism)
Vipera Subfamily Viperinae (organism)
Vipera persica Pseudocerastes persicus
Vipoma of uncertain behavior Vipoma, malignant
Viral gastroenteritis due to other viral agents Viral gastroenteritis
Viral hepatitis, non-A, non-B Viral hepatitis C
Viral infection by site Viral disease
Viral screening NOS Viral screening
Viral screening NOS Viral screening
Visceral epilepsy Focal epilepsy
Viscosity modifier Viscosity modifier (substance)
Visible light therapy NOS Visible light therapy
Visible light therapy NOS Visible light therapy
Visual defect - remedial therapy NOS Visual defect-remedial therapy
Visual defect - remedial therapy NOS Visual defect-remedial therapy
Visual symptom NOS Visual symptoms
Visual symptom NOS Visual symptoms
Visual testing NOS Visual testing
Visual testing NOS Visual testing
Visually threatening diabetic retinopathy Visually threatening diabetic retinopathy
Vitamin A deficiency with other ocular manifestations Vitamin A deficiency with ocular manifestation
Vitamin B12 preparation allergy Allergy to vitamin B12 and/or vitamin B12 derivative (finding)
Vitamin B>12< deficiency neuropathy Subacute combined degeneration of spinal cord
Vitamin D3 metabolite Vitamin D analogue
Vitamin P preparation Bioflavonoid
Vitamin preparation Vitamin supplement (substance)
Vitropression Diascopy procedure
Vocal Vocal resonance
Vocational trainer NOS Vocational trainer
Vocational trainer NOS Vocational trainer
Vocational training NOS Vocational training
Vocational training NOS Vocational training
Voice disorder due to transsexualism Speech and language disorder
Voiding pressure studies of bladder Urinary pressure and flow study
Voiding urethrocystography Fluoroscopic micturating cystourethrography (procedure)
Volatile inhalant dependence with current use Volatile inhalant dependence
Volume controlled ventilation Continuous mandatory ventilation (regime/therapy)
Voluntary body piercing Body piercing (finding)
Voluntary body tattooing Tattoo of skin
Vomit examination NOS Vomit examination
Vomit examination NOS Vomit examination
Vomit examination general NOS Vomit examination
Vomit occult blood NOS Occult blood detected in vomitus
Vomit occult blood NOS Vomit occult blood
Vomit odor NOS Odor of vomit
Vomit odour NOS Vomit odor - finding
Vomit pH NOS Vomit pH - finding
Vomit pH NOS Measurement of vomit pH
Vomit toxicology NOS Vomit toxicology
Vomit toxicology NOS Vomit toxicology
Vomit: appearance NOS Vomit appearance - finding
Vomit: appearance NOS Vomit appearance
Vomiting Vomiting (disorder)
Vomiting NOS Vomiting (disorder)
Vomiting NOS Vomiting (disorder)
Vomiting associated with other psychological disturbances Psychogenic vomiting
Vomiting disorder Vomiting (disorder)
Vomiting of pregnancy NOS Vomiting of pregnancy
Vomiting of pregnancy NOS Vomiting of pregnancy
Vulva TNM finding American Joint Committee on Cancer allowable value
Vulval/perineal trauma during delivery NOS Trauma to perineum and/or vulva during delivery (disorder)

Start Previous Page 220 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start